Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30043792HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043793HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043794HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043795HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043796HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043797HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043798HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043799HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043800HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043801HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TCGA Plot Options
Drug Information
GeneTOP2A
DrugBank IDDB04967
Drug NameLucanthone
Target IDBE0000742
UniProt IDP11388
Regulation Typeinhibitor
PubMed IDs9169823; 10487533; 11752352
CitationsBases RE, Mendez F: Topoisomerase inhibition by lucanthone, an adjuvant in radiation therapy. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1133-7.@@Dassonneville L, Bailly C: Stimulation of topoisomerase II-mediated DNA cleavage by an indazole analogue of lucanthone. Biochem Pharmacol. 1999 Oct 15;58(8):1307-12.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsInvestigational
Direct ClassificationThiochromenes
SMILESCCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1
Pathways
PharmGKBPA164748783
ChEMBLCHEMBL279014